The cheapest way to get Zepbound right now is through Eli Lilly’s self-pay vial program, which starts at $299 per month for the lowest dose. That’s a fraction of the retail price, which can exceed $1,000 per month at higher doses. But several other strategies can bring the cost down further depending on your insurance situation, and they’re worth understanding before you commit to paying full price.
LillyDirect Self-Pay Vials: The Lowest Cash Price
Eli Lilly introduced single-dose vials of Zepbound at significantly reduced prices through its direct pharmacy program called LillyDirect. The pricing through the Zepbound Self Pay Journey Program breaks down by dose:
- 2.5 mg: $299/month
- 5 mg: $399/month
- 7.5 mg through 15 mg: $449/month
Without the self-pay program, vial prices climb steeply at higher doses: $599 for 7.5 mg, $699 for 10 mg, $849 for 12.5 mg, and $1,049 for 15 mg. Enrolling in the journey program is essential if you’re paying out of pocket, since it caps every maintenance dose at $449. These are single-dose vials rather than the KwikPen auto-injector, so you’ll draw the medication yourself using a syringe, but the drug inside is identical.
The Manufacturer Savings Card for Insured Patients
If you have commercial (employer or marketplace) insurance that doesn’t cover Zepbound, Lilly offers a savings card that brings your cost to as low as $499 per month for up to four single-dose pens. That’s less than half the typical retail price of roughly $1,270 for the pen version. The card allows up to 13 fills per calendar year and expires at the end of 2026.
There are a few restrictions. You need a prescription for an FDA-approved use of Zepbound. People on government insurance, including Medicare, Medicaid, and Tricare, cannot use the savings card. You’re also ineligible if your insurance plan participates in an alternate funding program, which some employers use to route specialty drug purchases through third-party vendors. If you’re unsure whether your plan does this, your HR department or pharmacy benefit manager can tell you.
Getting Insurance to Cover It
Insurance coverage for Zepbound typically requires prior authorization, meaning your prescriber submits documentation proving you meet specific medical criteria. The requirements vary by plan, but common thresholds include a BMI of 30 or higher, height and weight measurements taken within the last 90 days, and confirmation that you’re not taking another medication in the same drug class. Some plans only cover Zepbound for obstructive sleep apnea rather than weight management, which adds requirements like a recent sleep study showing at least 15 breathing interruptions per hour.
If your plan denies coverage, you have the right to appeal. Ask your prescriber to submit a letter of medical necessity that outlines your weight history, related health conditions, and any prior treatments you’ve tried. Many denials are reversed on appeal, especially when documentation is thorough. Some plans also have a formulary exception process that can add Zepbound to your coverage if your prescriber demonstrates that alternative medications aren’t appropriate for you.
Discount Platforms Like GoodRx
Third-party discount cards from platforms like GoodRx can bring the retail price of Zepbound down to around $995 at major pharmacies including Walgreens, Walmart, CVS, and Target. That’s roughly 22% off the average retail price of $1,271. However, $995 is still significantly more than the $299 to $449 range available through LillyDirect’s vial program. GoodRx coupons make the most sense if your prescriber specifically writes for the KwikPen formulation and you prefer not to use vials, but for most self-pay patients, LillyDirect is the better deal.
HSA and FSA Funds
If you have a health savings account or flexible spending account, you can use those pre-tax dollars to pay for Zepbound. Weight loss drugs are eligible for reimbursement through an HSA, FSA, or health reimbursement arrangement as long as you have a valid prescription. This doesn’t reduce the sticker price, but it effectively gives you a discount equal to your marginal tax rate. If you’re in a 24% tax bracket, for example, paying $449 per month with HSA funds saves you roughly $108 per month compared to using after-tax income.
Medicare Coverage Starting Mid-2026
Medicare Part D has historically excluded weight loss drugs, but a new short-term program called the Medicare GLP-1 Bridge will begin covering Zepbound for eligible beneficiaries starting July 1, 2026, running through December 31, 2027. The program covers the KwikPen formulation of Zepbound when used for weight reduction, though not the single-dose vial or single-dose pen versions. If you’re already using Zepbound for an indication that Part D covers separately, like moderate to severe obstructive sleep apnea in adults with obesity, your coverage would go through your Part D plan’s standard process rather than the bridge program.
What About Compounded Tirzepatide?
Compounded versions of tirzepatide (the active ingredient in Zepbound) have been available from some pharmacies at lower prices, and you’ll find them advertised widely online. The risks here are real and documented. The FDA has received 545 adverse event reports associated with compounded tirzepatide. Some of those reports involved fraudulent products with fake pharmacy names on the label, medications that arrived without proper refrigeration, and dosing errors that led to hospitalization.
The dosing issue is particularly common. Unlike the pre-filled Zepbound pen, compounded tirzepatide often comes in multi-dose vials that require you to measure each injection yourself. Patients and even some healthcare providers have miscalculated doses, leading to serious side effects like severe nausea, vomiting, and abdominal pain. The FDA has also flagged cases where compounding pharmacies prescribed doses higher than those in Zepbound’s approved labeling, or accelerated the dose increase schedule beyond what’s been studied for safety.
Compounded drugs are only supposed to be used when an FDA-approved version can’t meet a patient’s medical needs. With Lilly’s vial program now offering Zepbound at $299 to $449 per month, the price gap between brand-name and compounded versions has narrowed considerably, making the tradeoff harder to justify.
Lilly Cares Patient Assistance
Lilly operates a patient assistance program called Lilly Cares for people who can’t afford their medications, with income limits ranging from 300% to 500% of the federal poverty level depending on the drug. For a single person, that means a household income cap between roughly $48,000 and $80,000. However, Zepbound is not currently listed as a covered medication in the Lilly Cares program. This could change, so it’s worth checking periodically if your income falls within those ranges.